Advanced Multi-Cancer Early Detection Screening

No. Multi-cancer early detection (MCED) testing is intended to complement—not replace—recommended cancer screenings such as mammograms, colonoscopies, Pap tests, PSA testing, and low-dose CT lung screening when appropriate. These traditional screenings remain an important part of preventive care and are often the most effective way to detect certain cancers early. MCED testing may provide additional information that can help identify potential cancer signals that might otherwise go undetected.

Coverage for multi-cancer early detection testing varies depending on your insurance plan, benefits, and the specific test being performed. While some patients may have coverage available, others may be responsible for some or all of the cost. Because insurance policies and reimbursement guidelines continue to evolve as these technologies become more widely adopted, we recommend speaking with your insurance carrier directly regarding your individual benefits. 

Cancer screening through Galleri® and CancerGuard™ is performed using a simple blood draw. The blood sample is analyzed using advanced technology designed to detect biological signals that may be associated with multiple types of cancer.

Eligibility can vary depending on factors such as age, personal health history, family history, and individual risk factors. These tests are often considered by adults who are interested in taking a proactive approach to their health and discussing additional screening options beyond traditional cancer screenings. Your provider can help determine whether this type of testing may be appropriate for your individual situation.

A positive or detected cancer signal does not necessarily mean that cancer is present. If a test identifies a signal that warrants further evaluation, your provider will review the results with you and discuss appropriate follow-up testing or referrals. Additional imaging, laboratory testing, or specialist consultations may be recommended to gather more information and determine the next steps.

Many cancers are most treatable when identified in their earliest stages, often before symptoms develop. While no screening test can detect every cancer, advances in early detection technology may help identify potential concerns sooner, allowing patients and providers to make informed decisions about additional evaluation and treatment when necessary.